Business Development & Licensing

A clear commercialization strategy is essential.

Early-stage biopharma companies may be highly skilled at presenting the scientific merits around their novel discovery but investors also need to clearly understand how this translates to commercial potential for the product and their opportunity for an exit. A clear licensing/ commercialization strategy will help attract the right investors and ensure the required level of funding is available to support the transition from preclinical to clinical.

BD & LICENSING EXPERIENCE

A track record of successful licensing and financing transactions.

PROVEN LICENSING SUCCESS

B4D has a track record of concluding licensing deals in the biotech and pharma world including co-development, co-marketing, tech transfer, early stage, late stage and marketed product agreements. We are experts in deal structure and knowledgeable in comparative deal terms and negotiations.

FINANCING

B4D has written grants, found seed money, introduced clients to investors/venture capitalists and presented at financing conferences globally. We have contacts within the local, provincial, national, and international financial circles.

BD NETWORK

With an established network of contacts, B4D can search for partners more cost-effectively. As B4D has often met contacts in person before, a virtual meeting model becomes even more efficient.

B4D Solutions

Service 5: Business

B4D will develop a licensing strategy that identifies the highest value inflection point for your project and optimal timing for out-licensing. We develop risk-adjusted project valuations and find deal comparables. Based on our industry experience we can advise on which potential partners to approach and the key data they will want to see.

Initial planning includes identifying potential partners through our industry network. Cost effective means such as licensing meetings can help build rapport with potential partners and anticipation for the product. Details about any licensing information can be broadcast in various ways, raising awareness without divulging confidential information. Once confidentiality agreements are in place, the selected partners are kept informed about milestone development events such as IND approvals and positive clinical data.

B4D has a network of financing contacts and can help identify appropriate sources of funding for your project – for example seed financing from non-dilutive government grants or equity-based venture capital financing. We monitor new funding opportunities and can match companies with sources most likely to succeed.

B4D has a network of financing contacts and can help identify appropriate sources of funding for your project – for example seed financing from non-dilutive government grants or equity-based venture capital financing. We monitor new funding opportunities and can match companies with sources most likely to succeed.

We work with you to ensure your financing and licensing presentations include the key elements investors need to make a decision. We know which partnering meetings yield the best results and can attend meetings and present for your company or as a part of your team.